Ventured Growth with Hercules Capital · Hercules Capital

#27 – The Evolution of Biotech: Lessons From 35 Years of Early Stage Investing | Terry McGuire

·34 min

Terry McGuire starts from venture history. The episode places him as a founding partner at Polaris Partners, with over 35 years of early stage investing across medical and information technology companies. His point of view is plainspoken: venture runs on relationships, and the limited partner world has become more layered as funds, corporate partners, and investors learn how to work together. The market matters too. In a harder environment, people find out who is really staying at the table. The conversation spends time on corporate venture arms and the slow adjustment between established funds and corporate partners. McGuire describes corporate partners as limited partners and investors in funds, but he keeps pulling the discussion back to alignment across all investors. Returns still drive the job. The best corporate partners, in his view, understand that a fund has responsibilities beyond any one strategic relationship. People are the hinge. Even when institutions change, he sees real value in the individuals who remain steady inside those corporate roles. The host then asks how new funds can build those relationships today, and McGuire answers without dressing it up: relationships compound as people move between firms and partnerships change shape. The close steps back to COVID, where big pharma, government, payers, and providers coordinated in a way that no single company could have managed alone.

As heard by us

A steady look at venture relationships and life sciences, shaped by Terry McGuire's long experience.

Janice Bork guides a conversation with Terry McGuire, a founding partner of Polaris Partners with 35-plus years of early-stage investing in medical and information technology companies.

Read the full review in PlayNext →

Why you'd press play

35 years of early-stage investing, filtered through one practical venture conversation.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify